BioCentury
ARTICLE | Clinical News

Apatorsen: Final Ph II data

November 10, 2016 11:25 PM UTC

Final data from the investigator-led, open-label, U.S. Phase II Borealis-2 trial in 200 patients with metastatic bladder cancer whose disease progressed following first-line, platinum-based chemothera...